| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1001184455 |
| P356 | DOI | 10.1007/S00408-003-1035-9 |
| P698 | PubMed publication ID | 14749937 |
| P2093 | author name string | H Satoh | |
| H Ishikawa | |||
| K Sekizawa | |||
| M Sumi | |||
| Y Funayama | |||
| K Kagohashi | |||
| P2860 | cites work | Hypoxia down-regulates endostatin production by human microvascular endothelial cells and pericytes | Q34100890 |
| The prognostic molecular markers in hepatocellular carcinoma | Q34668320 | ||
| Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage IV clear cell renal cancer | Q38462737 | ||
| Diagnosis and management of malignant pleural effusions | Q40551721 | ||
| Pleural effusion as a significant prognostic factor in non-small cell lung cancer. | Q50903950 | ||
| Tumor markers in pleural effusion diagnosis | Q68123172 | ||
| Clinical evaluation of CYFRA 21-1 in malignant pleural fluids | Q71687879 | ||
| Serum levels of vascular endothelial growth factor, basic fibroblast growth factor and endostatin in human metastatic liver tumors | Q73399199 | ||
| Increased concentrations of the circulating angiogenesis inhibitor endostatin in patients with systemic sclerosis | Q73678554 | ||
| Serum endostatin levels in patients with hepatocellular carcinoma | Q74170706 | ||
| Diagnostic value of C-reactive protein in exudative pleural effusions | Q74308752 | ||
| Biomarkers of intrinsic angiogenic and anti-angiogenic activity in patients with endometrial hyperplasia and endometrial cancer | Q74370594 | ||
| Serum endostatin correlates with progression and prognosis of non-small cell lung cancer | Q77370721 | ||
| Circulating angiogenic cytokines as tumour markers and prognostic factors in head and neck squamous cell carcinoma | Q77791322 | ||
| Serum concentrations of endostatin in patients with vulvar cancer | Q77933282 | ||
| Soluble aminopeptidase N/CD13 in malignant and nonmalignant effusions and intratumoral fluid | Q78632802 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 329-34 | |
| P577 | publication date | 2003-01-01 | |
| P1433 | published in | Lung | Q15765075 |
| P1476 | title | Endostatin levels in exudative pleural effusions | |
| P478 | volume | 181 |
| Q37730006 | Advances in the investigation and treatment of pleural effusions |
| Q46632685 | Angiogenic factors and angiogenesis inhibitors in exudative pleural effusions |
| Q51630933 | Diagnostic accuracy of endostatin for malignant pleural effusion: A clinical study and meta-analysis. |
| Q33585979 | Diagnostic and prognostic significance of lysophosphatidic acid in malignant pleural effusions |
| Q37889963 | Diagnostic molecular biomarkers for malignant pleural effusions. |
| Q54318375 | Transcription expression and clinical significance of vascular endothelial growth factor mRNA and endostatin mRNA in pleural effusions of patients with lung cancer. |
Search more.